Kornbluh A, Liu G, Hopkins SE: Delayed visual improvement in pediatric myelin oligodendrocyte glycoprotein antibody-associated optic neuritis. Pediatric Neurology Page: 43-45, October 2021.
Greenberg B, Plumb P, Cutter G, Dean J, Desena A, Hopkins S, Krishnan C, Pardo C, Recio A, Schreiner T, Yeh EA, McCreary M.: Acute flaccid myelitis: long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitis. BMJ Neurol Open 19(3), May 2021.
Le H. Hua, Ahmed Z Obeidat, Lilyana Amezcua, Jeffrey A. Cohen, Kathleen M Costello, Jeffrey Dunn, Jeffrey Marc Gelfand, Myla D. Goldman, Sarah Hopkins, Douglas R. Jeffery, Stephen C Krieger, Scott Douglas Newsome, Suma Shah, Nancy L. Sicotte, Vijayshree Yadav, and Erin Longbrake: Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurology: Clinical Practice January 2021.
Murphy OC, Messacar K, Benson L, Bove R, Carpenter JL, Crawford T, Dean J, DeBiasi R, Desai J, Elrick MJ, Farias-Moeller R, Gombolay GY, Greenberg B, Harmelink M, Hong S, Hopkins SE, Oleszek J, Otten C, Sadowsky CL, Schreiner TL, Thakur KT, Van Haren K, Carballo CM, Chong PF, Fall A, Gowda VK, Helfferich J, Kira R, Lim M, Lopez EL, Wells EM, Yeh EA, Pardo CA; AFM working group.: Acute Flaccid Myelitis: Cause, diagnosis and Management. The Lancet 397(10271): 334-346, January 2021.
Chadrhumbe M and Hopkins S: Chapter 14: Neurological features associated with the chromosome 22q11.2 deletion syndrome in The Chromosome 22q11.2 Deletion Syndrome. book. Elsevier, 2021
Hopkins S, Desai J, Benson L: Acute Flaccid Myelitis: A call for vigilance and an update on management. Pediatric Neurology 114: 26-58, September 2020.
Hardy D, Hopkins SE: Update on acute flaccid myelitis: recognition, reporting, aetiology and outcomes. Archives of Disease in Childhood Feb 2020 Notes: Published Online First: 10 February 2020.
Margaret M. Cortese, Anita K. Kambhampati, Jennifer E. Schuster, Zaid Alhinai,Gary R. Nelson, Gloria J. Guzman Perez-Carrillo, Arastoo Vossough, Michael A. Smit, Robert C. McKinstry, Timothy Zinkus, Kevin R. Moore, Jeffrey M. Rogg, Meghan S. Candee, James J. Sejvar, Sarah E. Hopkins : A ten-year retrospective evaluation of acute flaccid myelitis at 5 pediatric centers in the United States, 2005-2014. PLOS One February 2020.
Ayers T, Lopez A, Lee A, Kambhampati A, Nix WA, Henderson E, Rogers S, Weldon WC, Oberste MS, Sejvar J, Hopkins SE, Pallansch MA, Routh JA, Patel M.: Acute Flaccid Myelitis in the United States: 2015-2017. Pediatrics 144(5), November 2019.
Priyanka Uprety, Darcy Curtis, Michael Elkan, Jeffrey Fink, Ramakrishnan Rajagopalan, Chunyu Zhao, Kyle Bittinger, Stephanie Mitchell, Erlinda R. Ulloa, Sarah Hopkins, and Erin H. Graf: Enterovirus D68 Surveillance, Association with Acute Flaccid Myelitis and Whole Genome Investigation, Philadelphia, Pennsylvania, USA, 2009-2018. Emerging Infectious Diseases 25(9): 1676-1682, August 2019.
Messacar Kevin, Sillau Stefan, Hopkins Sarah E, Otten Catherine, Wilson-Murphy Molly, Wong Brian, Santoro Jonathan D, Treister Andrew, Bains Harlori K, Torres Alcy, Zabrocki Luke, Glanternik Julia R, Hurst Amanda L, Martin Jan A, Schreiner Teri, Makhani Naila, DeBiasi Roberta L, Kruer Michael C, Tremoulet Adriana H, Van Haren Keith, Desai Jay, Benson Leslie A, Gorman Mark P, Abzug Mark J, Tyler Kenneth L, Dominguez Samuel R: Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. Neurology 92(18): e2118-e2126, April 2019.
Campbell IM, Sheppard SE, Crowley TB, McGinn DE, Bailey A, McGinn MJ, Unolt M, Homans JF, Chen EY, Salmons HI, Gaynor JW, Goldmuntz E, Jackson OA2, Katz LE, Mascarenhas MR, Deeney VFX, Castelein RM, Zur KB, Elden L, Kallish S, Kolon TF, Hopkins SE, Chadehumbe MA, Lambert MP, Forbes BJ, Moldenhauer JS, Schindewolf EM1, Solot CB, Moss EM, Gur RE, Sullivan KE, Emanuel BS, Zackai EH, McDonald-McGinn DM. What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia. Am J Med Genet A. 2018 Oct;176(10):2058-2069. doi: 10.1002/ajmg.a.40637.
Morlet T, Nagao K, Bean SC, Mora SE, Hopkins SE, Hobson GM. Auditory function in Pelizaeus-Merzbacher disease. J Neurol. 2018 May 3. doi: 10.1007/s00415-018-8884-x. [Epub ahead of print]
Johannesen KM, Gardella E, Linnankivi T, Courage C, de Saint Martin A, Lehesjoki AE, Mignot C, Afenjar A, Lesca G, Abi-Warde MT, Chelly J, Piton A, Merritt JL 2nd, Rodan LH, Tan WH, Bird LM, Nespeca M, Gleeson JG, Yoo Y, Choi M, Chae JH, Czapansky-Beilman D, Reichert SC, Pendziwiat M, Verhoeven JS, Schelhaas HJ, Devinsky O, Christensen J, Specchio N, Trivisano M, Weber YG, Nava C, Keren B, Doummar D, Schaefer E, Hopkins S, Dubbs H, Shaw JE, Pisani L, Myers CT, Tang S, Tang S, Pal DK, Millichap JJ, Carvill GL, Helbig KL, Mecarelli O, Striano P, Helbig I, Rubboli G, Mefford HC, Møller RS. Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia. 2018 Feb;59(2):389-402. doi: 10.1111/epi.13986. Epub 2018 Jan 8.
Hopkins SE. Acute Flaccid Myelitis: Etiologic Challenges, Diagnostic and Management Considerations. Curr Treat Options Neurol. 2017 Nov 28;19(12):48. doi: 10.1007/s11940-017-0480-3.
Kessler RA, Mealy MA, Jimenez-Arango JA, Quan C, Paul F, López R, Hopkins S, Levy M.: Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study. Multiple Sclerosis and Related Disorders 17: 198-201, October 2017.
Narula S, Hopkins SE, Banwell B. Treatment of pediatric multiple sclerosis. Curr Treat Options Neurol. 2015 Mar;17(3):336. doi: 10.1007/s11940-014-0336-z.
Sweeney M, Rubin J, Hopkins SE. Neurogenic pulmonary edema in pediatric multiple sclerosis: patient report and summary of cases. Pediatr Neurol. 2014 Sep;51(3):426-9. doi: 10.1016/j.pediatrneurol.2014.04.023. Epub 2014 Apr 29.
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.